102 related articles for article (PubMed ID: 7754496)
1. [Target dose markers. Exposure indicators for environmental epidemiological studies].
Dybing E; Alexander J
Tidsskr Nor Laegeforen; 1995 Apr; 115(10):1249-52. PubMed ID: 7754496
[TBL] [Abstract][Full Text] [Related]
2. Human biomonitoring: state of the art.
Angerer J; Ewers U; Wilhelm M
Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
[TBL] [Abstract][Full Text] [Related]
3. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
Farmer PB; Singh R
Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
[TBL] [Abstract][Full Text] [Related]
4. [Biologically effective dose biomarkers].
Miraglia N; Assennato G; Clonfero E; Fustinoni S; Sannolo N
G Ital Med Lav Ergon; 2004; 26(4):298-301. PubMed ID: 15584436
[TBL] [Abstract][Full Text] [Related]
5. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
[TBL] [Abstract][Full Text] [Related]
6. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies.
Hudnell HK
Neurotoxicology; 1999; 20(2-3):379-97. PubMed ID: 10385898
[TBL] [Abstract][Full Text] [Related]
7. [Biomarkers of gentotoxic risk and metabolic polymorphism].
Pavanello S; Clonfero E
Med Lav; 2000; 91(5):431-69. PubMed ID: 11189784
[TBL] [Abstract][Full Text] [Related]
8. Biologic markers of exposure: current status and future research needs.
Vine MF
Toxicol Ind Health; 1996; 12(2):189-200. PubMed ID: 8794532
[TBL] [Abstract][Full Text] [Related]
9. [Dosimetry of DNA and protein adducts in occupational health].
Pavanello S; Clonfero E
Med Lav; 1994; 85(5):363-9. PubMed ID: 7885291
[TBL] [Abstract][Full Text] [Related]
10. Human exposure assessment to environmental chemicals using biomonitoring.
Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
[TBL] [Abstract][Full Text] [Related]
11. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
Farmer PB
IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of acceptable exposure levels to industrial and environmental pollutants: problems raised because of the interpretation of epidemiological data].
Lauwerys R
Bull Mem Acad R Med Belg; 1996; 151(5-6):295-303; discussion 304-5. PubMed ID: 9156670
[TBL] [Abstract][Full Text] [Related]
13. Biological markers and risk assessment.
Goldstein BD
Drug Metab Rev; 1996; 28(1-2):225-33. PubMed ID: 8744599
[TBL] [Abstract][Full Text] [Related]
14. Children's exposure to environmental pollutants and biomarkers of genetic damage. I. Overview and critical issues.
Neri M; Bonassi S; Knudsen LE; Sram RJ; Holland N; Ugolini D; Merlo DF
Mutat Res; 2006 Jan; 612(1):1-13. PubMed ID: 16002329
[TBL] [Abstract][Full Text] [Related]
15. [From industrial hygiene and toxicology to environmental hygiene and toxicology: problems and prospects].
Carrer P; Cavallo D; Fustinoni S; Maroni M
Med Lav; 2003; 94(1):64-8. PubMed ID: 12768957
[TBL] [Abstract][Full Text] [Related]
16. Assessment of exposure in epidemiological studies: the example of silica dust.
Dahmann D; Taeger D; Kappler M; Büchte S; Morfeld P; Brüning T; Pesch B
J Expo Sci Environ Epidemiol; 2008 Sep; 18(5):452-61. PubMed ID: 18059424
[TBL] [Abstract][Full Text] [Related]
17. Pooled analysis of epidemiological studies involving biological markers.
Taioli E; Bonassi S
Int J Hyg Environ Health; 2003 Mar; 206(2):109-15. PubMed ID: 12708232
[TBL] [Abstract][Full Text] [Related]
18. Toxicological considerations in the application and interpretation of DNA adducts in epidemiological studies.
Swenberg JA
IARC Sci Publ; 2004; (157):237-46. PubMed ID: 15055299
[TBL] [Abstract][Full Text] [Related]
19. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
Kensler TW; Groopman JD
J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
[TBL] [Abstract][Full Text] [Related]
20. New developments in exposure assessment: the impact on the practice of health risk assessment and epidemiological studies.
Nieuwenhuijsen M; Paustenbach D; Duarte-Davidson R
Environ Int; 2006 Dec; 32(8):996-1009. PubMed ID: 16875734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
